StockData

Vanda Pharmaceuticals Inc. (VNDA) stock

VNDANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 10/3055% below fair value
$3.81+0.00 (0.00%)

Close on Nov 17, 2026Market cap $230.39MP/E –Yield –

Vanda Pharmaceuticals ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

For fiscal 2014 it was $20.59M. The highest annual figure on record is $20.59M in fiscal 2014.

Annual ebitda

PeriodPeriod endValueChange
FY2014Dec 31, 2014$20.59M–
FY2013Dec 31, 2013-$20.77M–
FY2012Dec 31, 2012-$28.55M–
FY2011Dec 31, 2011-$10.24M-211.6%
FY2010Dec 31, 2010$9.17M–
FY2009Dec 31, 2009-$35.51M–

More Vanda Pharmaceuticals figures

See a number that looks wrong?